Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.23.16 (
HIV-1 protease
)
2,107
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Better understanding of the mechanisms of proinflammatory cytokine production during human immunodeficiency virus (HIV) type 1 infection is of pivotal importance. The effect of HIV-1 infection on recombinant
CD40 ligand
(
CD40L
)-induced interleukin (IL)-1beta and IL-6 production by human macrophages was analyzed. ELISA and cytofluorometric analysis demonstrated that
CD40L
stimulation of HIV-1-infected macrophages resulted in substantial production of IL-1beta and IL-6. In contrast, no cytokine response was observed in uninfected cells. No modulation of the receptor for CD40 was found to account for the enhanced response to
CD40L
. The
CD40L
effect was not due to lipopolysaccharide contamination and was completely abrogated by preincubation with a monoclonal anti-
CD40L
antibody. mRNA studies indicated that the priming effect of HIV-1 on the macrophage response to
CD40L
was regulated at the transcriptional level. Finally, the effect of HIV-1 on the cytokine response could not be abolished by the
HIV-1 protease
inhibitor U75875 at concentrations that completely suppressed HIV-1 replication.
...
PMID:Human immunodeficiency virus type 1 infection modulates the interleukin (IL)-1beta and IL-6 responses of human macrophages to CD40 ligand stimulation. 1095 Jul 71